Compare ATOS & SDOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATOS | SDOT |
|---|---|---|
| Founded | 2009 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.1M | 23.1M |
| IPO Year | 2010 | 2019 |
| Metric | ATOS | SDOT |
|---|---|---|
| Price | $2.60 | $11.21 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $23.00 | N/A |
| AVG Volume (30 Days) | 49.4K | ★ 1.2M |
| Earning Date | 05-13-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 490.91 |
| EPS | ★ N/A | N/A |
| Revenue | $1,758.00 | ★ $7,929,137.00 |
| Revenue This Year | N/A | $12.76 |
| Revenue Next Year | N/A | $5.54 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 60.08 |
| 52 Week Low | $0.53 | $0.14 |
| 52 Week High | $7.56 | $106.00 |
| Indicator | ATOS | SDOT |
|---|---|---|
| Relative Strength Index (RSI) | 57.11 | 41.53 |
| Support Level | $0.58 | $11.00 |
| Resistance Level | $6.18 | $35.50 |
| Average True Range (ATR) | 0.16 | 1.35 |
| MACD | 0.06 | -0.29 |
| Stochastic Oscillator | 85.94 | 7.61 |
Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions. The company's lead product candidate, oral (Z)-endoxifen, is a selective estrogen receptor modulator and degrader (SERM/SERD) in Phase 2 clinical development, being evaluated for the treatment and prevention of breast cancer and other indications.
Sadot Group Inc consisted of one distinct operating unit engaged in the Agri-Foods industry. Its operating unit was intended to be a Agri-Foods company engaged in farming, commodity trading and shipping of food and feed (e.g., soybean meal, wheat and corn) via dry bulk cargo ships across the globe.